INFANS - INtegrating Functional Assessment measures for Neonatal Safeguard
From 01-01-2019 to 31-12-2023
Description
INFANS will train 15 ESRs with background from basic to clinical sciences in multiple aspects of neonatal brain monitoring. The need for a coordinated research training programme in neonatal brain monitoring arises from i) the severe shortage of clinically viable means to high quality monitor the brain function in infancy, crucial to prevent later life neurological, cognitive and motor impairment and ii) the lack of well-educated PhDs in this field. Through their individual research projects, encompassing technological innovation, industrial development, clinical validation, identification of neonatal healthcare needs, the INFANS ESRs will develop a novel platform for high quality, clinically-viable EEG-NIRS monitoring accessible worldwide. Excellent science, industrial leadership and societal challenge are merged in INFANS: 6 academic and 4 nonacademic partner from 6 EU countries, among which leading universities, industries, clinical institutions, share complementary expertise and facilities to provide international, interdisciplinary and intersectoral research training and mobility that will complement local doctoral training. Well-targeted visits and secondments, soft skills and dynamic training activities, an Open Science strategy, extensive involvement of ESRs in the network events organization, extensive contacts with other research, training and industrial European networks, dissemination activities and the award of Double doctoral degrees are further assets of INFANS. The ESRs will learn to transform a scientific/technological challenge into a product of socio-economic relevance, as the INFANS functional neuro-monitoring system will reduce the number of children with neurological, cognitive or motor dysfunctions associated with brain injuries at birth. The INFANS ESRs will become independent researchers with career prospects in both the academic and non-academic sectors, and will advance the EU capacity for innovation in biomedical engineering.
Grant Agreement #813483
Team
- Maarten De Vos, Co-promoter
- Sabine Van Huffel, Promoter
Financing
Funding: EU Funding - European Funding
Program/Grant Type: MSCA ITN - Marie Sklodowska-Curie Actions International Training Networks
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.